Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Evaluation of 68-GaNOTA-Anti-HER2 VHH1 Uptake in Brain Metastasis of Breast Carcinoma Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03331601
Recruitment Status : Recruiting
First Posted : November 6, 2017
Last Update Posted : March 7, 2022
Information provided by (Responsible Party):
Universitair Ziekenhuis Brussel